Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2025.
STATE STREET CORP - 31 Dec 2025 SCHEDULE 13G Report for CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- CLDX
- Shares outstanding
- 66,621,824 shares
- Disclosed Ownership
- 3,397,713 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Feb 2026, 06:26:21 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 5.1% ownership in CELLDEX THERAPEUTICS INC COMMON STOCK (CLDX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Feb 2026, 06:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 5.1% | 3,397,713 | 0 | 3,194,178 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |